Publication date: Jul 11, 2024
In this study, we report a preanalytical challenge noted in our laboratory on plasma samples from a critically ill COVID-19 patient treated with hydroxychloroquine. This is significant because, in critically ill COVID-19 patients on hydroxychloroquine, plasma samples can have a high measured haemolysis index in the absence of haemolysis, with the impact on reporting the results for potassium and other analytes.
| Concepts | Keywords |
|---|---|
| Covid | Anemia, Hemolytic |
| Haemolysis | Chemistry, Clinical |
| High | COVID-19 |
| Laboratory | |
| Potassium |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Haemolysis |
| disease | MESH | COVID-19 |
| disease | VO | report |
| disease | MESH | critically ill |
| drug | DRUGBANK | Hydroxychloroquine |
| drug | DRUGBANK | Potassium |
| disease | MESH | Anemia Hemolytic |
Original Article
(Visited 2 times, 1 visits today)